Increase Expected in Approved AI-Based Medical Imaging Products

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 7, 2023.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 7, 2023 -- The number of U.S. Food and Drug Administration (FDA)-approved artificial intelligence (AI) products is expected to increase from 69 in 2022 to 350 in 2035, according to a study published online Oct. 16 in the Journal of the American College of Radiology.

Nicole K. McNabb, from ACR Data Science Institute in Reston, Virginia, and colleagues attempted to estimate the number of new medical AI imaging products based on the association between historical funding (Rock Health; 2013 to 2022) and FDA-approved AI products (2008 to 2022).

The researchers found 11.33 new AI products for every $1 billion in funding, assuming a six-year lag between funding and product approval. There were 69 new FDA-approved products in 2022, which were associated with $4.8 billion in funding; this was up from 13 in 2018. Product-year funding is projected to reach $30.8 billion in 2035, resulting in 350 new products that year.

"AI is likely to change the practice of diagnostic radiology over time as new products are developed and integrated into practice," the authors write. "Furthermore, as AI products are integrated into practice, it may incentivize increased investment for future AI products."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-08 03:08

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords